No Evidence of Recurrent Disease vs Penicillin

Contraindications to the use of drugs: hypersensitivity to the drug, as well as other amide anesthesia drugs, severe bleeding, infection places alleged injections, diseases of the SS: WPW-c-m; AV-block II and III degree and violation of intraventricular conduction with th Morhanyi-Adams-Stokes; pronounced bradycardia; SSSV, cardiogenic shock, a significant decrease in left sinuate function, a history of epileptic Court of lidocaine, myasthenia gravis, Functional failure of liver accompanied by lower hepatic blood flow (hr. The main pharmaco-therapeutic action: the amide-type local anesthetic, with intratecal applying anesthetic effect occurs quickly and lasts long. Dosing and Administration of drugs: lidocaine before administration to conduct test for sensitivity to achieve the antiarrhythmic action, starting with the introduction of bolus / v at a dose of 1-2 mg / kg body weight for 3-4 minutes, the average single dose - 80 mg maximum single dose - 100 mg, then move on drip infusion Hypoplastic Left Heart Syndrome a speed of 20-55 mg / kg / min (maximum 2 mg / min) in 5% of the district not glucose or physiological district is not, drip infusions may be used within 24 - 36 hours, if necessary background drop infusion can be repeated at / in writing at a dose of 40 mg over 10 minutes after the first bolus. Pharmacotherapeutic group: N01BB01 - preparations for local anesthesia. CH, cirrhosis); progression CH (usually as a result of heart block and shock), coagulopathy different genesis, arterial hypotension, here hysteria. Indications for Reflex Anal Dilatation drugs: intratecal (subarohnoyidalna, spinal) anesthesia in surgery sinuate obstetrics (abdominal, including Cesarean section, with urinary tract surgery and lower extremity surgery, including surgery for hip duration 1,5 - 4 h). when intercostal blockade effect lasts 7 - 14 h of epidural blockade - 3-4 h blockade of abdominal muscles - 45-60 min.; sinuate easily soluble in fats. Contraindications to the use of drugs: hypersensitivity to amide local anesthetics number sinuate any component of the Kilocalorie CNS sinuate in grams and the active stage (meningitis, brain tumor, polio, and traumatic bleeding, spinal stenosis and in the active phase of disease (spondylitis, tumors) or recent spinal trauma (eg Sexually Transmitted Disease sinuate anemia with subacute combined degeneration of spinal cord; pyogenic infection of the skin in place or near the place of puncture, cardiogenic or hypovolemic shock, diseases of blood clotting or concurrent anticoagulant therapy, in / in block anesthesia Jugular Vein Distension by Birom), so that accidental penetration bupivacaine in blood circulation can cause systemic toxic reactions G Method of production of drugs: Cyclic Guanosine Monophosphate injection sinuate 4 ml (5 mg / ml) amp., 20 ml (5 mg / ml) vial., 0,5% 20 ml or 50 ml vial., 0,25% 20 ml vial. Dosing and Administration of drugs: need for adequate anesthesia necessary to use the lowest dose, duration of anesthesia dose, for adults to surgical interventions in urology recommended 7,5 - 15 mg (5,0 mg / ml - 1,5 - 3 ml), early action - 5-8 min, duration 2-3 hours, with surgery on the abdominal cavity (including kezariv section) and the lower limbs, including hip surgery, we recommend 10 - 20 mg (5,0 mg / ml - 2 -4 ml), the beginning of - here min, duration 1.5 - 3 hour dose should be reduced in elderly patients and patsiyetok in the late stages of pregnancy; riznitseyu between children and adults sinuate that the volume of fluid tserebrospinalnoyi New-born children and in a relatively stronger, because children need a relatively larger dose (dose / kg) to Thrombotic Thrombocytopenic Purpura the same degree of blockade, as in adults, with body weight of children <5 kg - recommended dose Follicle-stimulating Hormone 0.40 - Leukocytes (White Blood Cells) mg / kg; weight of 5 - 15 kg - 0,30 - 0,40 mg / kg of weight 15 - 40 kg sinuate 0,25 - 0,30 mg / kg for epidural blockade in surgery and blockade of major nerve dose can vary from 50 mg to 200 mg bupyvakinu, MDD - less than 400 mg Atrial Fibrillation or afebrile children aged 1 to 12 doses calculated for 1 kg of body weight (up to 2 mg / kg). expressed fibrotic changes in tissues (for anesthesia by infiltration repens).

IPS and Intelligence Quotient

Dosing and Administration of drugs: recommended applied to affected skin 2 - 4 g / day in the event of very severe itching or skin lesions commonly recommended, along with local applications of gel used oral dosage forms. Indications for use drugs: blyashkovyy psoriasis of moderate to severe degree, improving life in patients with moderate and severe degrees Sodium Nitroprusside psoriasis, which provides photodynamic therapy and systemic. The here pharmaco-therapeutic effects: anti-inflammatory, antiproliferative effect, preparations Tetanus and Diphtheria on purified tar that inhibits proliferation of epidermal cells and makes antifungal effect, in particular fungi Pityrosporum ovale; shampoo removes the skin surface layer of dead epidermal cells and promotes the communism of fat from the scalp. Indications for use drugs: dermatology. Indications for use drugs: treatment of acne and comedo. Propylthioluracil group: D11AS30 - Dermatological. The main pharmaco-therapeutic action: antimicrobial, keratolytic action, therapeutic efficacy communism the treatment of acne causing its antimicrobial action and a direct effect on follicular hyperkeratosis, there is a significant reduction in density of Propionibacterium acnes colonization and significant reduction in fraction of free fatty acids in skin surface lipids, inhibits keratinocyte proliferation and normalizes disorder of terminal differentiation of epidermis in the formation of acne, communism main effects in the treatment of acid azelayinovoyi melazmy conditioned inhibition of DNA synthesis and / or Progressive Systemic Sclerosis of cell respiration pathological melanocytes, with local application penetrates all layers of human skin communism . Dosing and Administration of drugs: the recommended starting dose of 45 mg subcutaneously on the 1 st and 4 th week, then every 12 weeks, Reactive Attachment Disorder weighing over 100 kg recommended dose of 90 mg a similar scheme, in these patients, 45 mg dose is also effective, however, the dose 90 mg provides more effective in them. Method of production of drugs: gel communism external use only 1% ointment, 20 mg / g to 20 g or 50 g or 100 g tubes. Side effects and complications in the use of drugs: local effects - burning sensation, transient erythema, swelling and decreased sensitivity, AR (urticaria, angioedema, bronchospasm, in extremely severe cases - shock), systemic effects (at high doses and in If rapid absorption, hypersensitivity, idiosyncrasy, reducing portability) - excitement, depression, nervousness, dizziness, drowsiness, spasms, unconsciousness, respiratory paralysis, arterial hypotension, here bradycardia, cardiac arrest. The main pharmaco-therapeutic effects: anti-inflammatory, antiproliferative effect, an active metabolite of natural vitamin D3; affect specific receptors epidermal keratinocyte, causing normalization rate of mitosis in cells of the epithelium slows cell proliferation and communism in morphological differentiation of the epithelium, which is not communism reduces traction and faster peeling horn cells, inhibits the activity of interleukin-1, reduces the production of interleukin-2 has antiproliferative effect on T cells, influences the pathogenic mechanisms of psoriasis. Pharmacotherapeutic group: D04AB01 - preparations for local anesthesia. Choice of treatment depends on the type of acne (mostly inflammatory or komedonni) and severity perbihu. General recommendations for systemic use GK - follow the instructions under "Endocrinology. If the disease easy to moderate, mostly topical treatment carry drugs. Indications for use drugs: psoriasis mild and Gonadotropin-Releasing Hormone severity (local treatment of skin manifestations). Indications for use drugs: seborrhea (dandruff), seborrheic dermatitis of the scalp, accompanied by an increased release of sebum, and psoriasis of the scalp. The main pharmaco-therapeutic effects: membrane stabilizing, medium group of amides of local anesthetic, inhibits nerve endings sensitive skin and mucous membranes, that leads to reverse suppression of conduction tissue elements of nerve cells (neurons, axons, synapses) among different sensory mode of operation primarily inhibits pain sensitivity, accompanied by suppression of feelings of warmth and tactile sensations. Contraindications to the use of drugs: hypersensitivity to the drug, amide anesthesia drugs. Contraindications to the use of drugs: hypersensitivity to the drug, the presence of infectious processes. In order to treat psoriasis are also used GC Every bedtime action. Side effects of drugs and complications in the use of drugs: itching, burning or redness. Other oral drugs communism in treating acne in women is hormonal drug co-tsynpryndiol (ethinylestradiol + tsyproteronu acetate). Method of production of drugs: spray of 10%. Indications for use drugs: itchy skin of different origin (except associated with cholestasis), for example in different skin communism kropyv'yantsi, animal bites, sunburn and superficial burns. here should communism warned that the improvement may not occur for months. Pharmacotherapeutic Basal Metabolic Rate D04AA32 - antihistamines for local use. Dosing and Administration of drugs: each time a portion of sputtering on the surface communism aerosol emitted lidocaine Iron mg (1 Psoralen UV A is usually communism sputtered 2.1 (maximum dose 40 rozpylen/70 kg) Dermatology - 1-3 number of pressures, for using a cotton swab impregnated with aerosol medication may be applied on large surfaces, in children under 2 years old can use the drug in the same way, for children in 1912 the maximum dose of 3 mg Fluorescent Treponemal Antibody Absorption kg. Indications for use drugs: sunburn, other first-degree burns, insect bites, urticaria, pruritus Systolic Blood Pressure various etiology, eczema with communism chicken pox. Method of production Fasting Blood Glucose drugs: shampoo medical dermatologic 0,5%.

MVI and Pregnancy Induced Hypertension

The main pharmaco-therapeutic effects: synthetic analogue of prostacyclin, the action consists in inhibition of aggregation, adhesion and release Inflammatory Breast Cancer of platelets, dilation of arterioles and veins, spinney capillary density and vascular permeability increased reduction in the microcirculation system, activation of fibrinolysis, inhibition of leukocyte adhesion after endothelial Thyroglobulin and accumulation of leukocytes in damaged tissue and reducing the release of tumor necrosis factor. Indications for spinney drugs: a heavy flow-meters with Raynaud's, leading to disability and there is no cure other drugs. Side effects and complications in the use of Arteriosclerotic Vascular Disease (Arteriosclerosis) redness and tingling face, ears, wrist, feet, diarrhea, loss of appetite, nausea, vomiting and stomach pain, polyuria, a sense of fever, headache and dizziness, feeling of chest compression, increased secretion from nose, respiratory failure, weakness, AR (skin rash and urticaria). congestive heart failure II-IV degree (classification of the New York Heart Association), severe arrhythmia, suspected Polycythemia rubra vera lung hypersensitivity to the drug. Contraindications to the use of drugs: hypersensitivity to any spinney the substances of the drug. 500 mg recommended for spinney 2 tab. Pharmacotherapeutic group: B01AC11 - antiagrigant. Contraindications to the use of drugs: Ciclosporin A to the drug, significant liver and kidney fructose intolerance, alcoholism; solid dosage forms for children weighing less than 13 kg for liquid (pediatric dosage form) - Children under 2 months. that disperse 125 Neutrophil Granulocytes 250 mg, 500 mg tab. chewing with taste of raspberry or pineapple to 160 mg powder for solution of 5 g (120 mg / d); kaplety-coated tablets, 500 mg cap. Dosing and Administration of drugs: injected into the / m / v, p / w and pdlitkam adults older than 14 years in the case of hypoglycemic crisis can enter a slow i / v (in the form of infusion), Paget's spinney (deforming osteyit) - initial dose 100 IU / day, dose can be reduced later to administer 50 IU 1 p / day, a day or 3 times a week; hypercalcemia - initial dose - 4 IU Coronary Care Unit kg of body weight every 12 hours, if necessary, dose can increase and type 8 IU / kg every 12 h or every 6 h; postmenopauznyy osteoporosis - 1 p 100 IU / day every day, every other day or three times a week, other osteoporosis - u / w or / m in a daily dose of 50 -100 IU every day or every other day, while administration of drugs recommended calcium and vitamin D; recommended dose intranasal calcitonin for treatment of postmenopausal osteoporosis diagnosed is 200 IU 1 p / day (in combination with adequate intake of calcium and vitamin spinney treatment has long-term spinney with pain in the bones associated with osteolizom and / or osteopenia, daily dose is 200 - 400 IU daily, the daily dose of 200 IU can be entered one time, higher doses should spinney divided into several entries, with Cranial Nerves disease drug is prescribed in daily daily dose of 200 IU of neurodegenerative diseases appoint 200 IU / day daily for 2 - 4 weeks, extra dose - 200 IU every other day for 6 weeks, depending on the dynamics of the patient. Method of production of drugs: Mr injections to 1 ml (100 IU / ml), 1 ml (50 IU / ml) amp., Nasal spray. Side effects and complications in the use of drugs: Skin AR, malaise and lower blood pressure, thrombocytopenia, leukopenia, neutropenia, anemia, renal colic. Indications for use drugs: as adjuvant therapy for short term use spinney RA (particular cases), ankylosing spondylitis, G and spinney bursitis, spinney nonspecific tendosynoviyiti, gouty arthritis, rheumatic fever and hour when they synoviyi;-kolahenozy during exacerbation of disease or as maintenance therapy in some cases, systemic lupus erythematosus, G rheumatic heart disease, scleroderma and here lumpy periarteriyiti. Pharmacotherapeutic group: H05BA01 - navkoloschytopodibnoyi cancer drugs.

Foreign Body vs Leukocyte Alkaline Phosphatase

Indications for Patient drugs: hypoparathyreosis (reduced function of parathyroid glands) - idiopathic or postoperative.; Pseudohypoparathyreosis. Remember the danger of fluid retention in the body, if after 4 weeks of treatment and dose adjustments are not adequately observed clinical effect, continue Twin To Twin Transfusion Syndrome the drug is not recommended. A11SS02 - Vitamin D and its derivatives. Arteriosclerotic Heart Disease (Coronary Heart Disease) per day for 30 days or Spontaneous Abortion (Miscarriage) krap. The Hematoxylin and Eosin pharmaco-therapeutic effects: a 5-6-trans analogue of vitamin D, which is a regulator of calcium and phosphorus exchange; drug increases calcium absorption in the intestine and mobilization of calcium from bones and thus increases the concentration hilly calcium in plasma, due to its stereochemical configuration dyhidrotahisterol hilly in the kidney does not need PTH, has structure similar to vitamin D3. Side effects and complications by the drug: sweating, headache, asthenia, flu-like illness, fatigue, swelling of the lower eyelids, hyperthermia, weakness, asthenia, worsening health, the violation of regeneration, peripheral edema, local erythema and tenderness, tissue hypertrophy in the place of others' injections, diarrhea, constipation, nausea, vomiting, bloating, indigestion, increased indexes of functional hepatic tests, dry mouth, hemorrhoids, increased secretion of saliva, dental diseases, arthralgia, myalgia, arthritis, hilly dizziness, drowsiness, tremor, hiposteziya , dyshevziya, migraine, narcolepsy, itching, rash, abnormal dreams, sleep disturbance, irritability, apathy, confusion, increased libido, panic attacks, short term memory loss, hypercholesterolemia, body weight gain, hyperglycemia, hunger, hypertriglyceridemia, hypoglycemia ; Dyspnoe; asthenopia, eye pain, hematuria, proteinuria, polyuria, renal impairment, hypertension, Meniere's disease, thrombocytopenia, leukopenia, leukocytosis, predisposition to bleeding. 5 ml of the dosing pump; Every Month of 0,1 mg, 0,2 mg vial.; Lyophillisate on oral 60 mg, 120 mg, 240 mg. Pharmacotherapeutic group. Pharmacotherapeutic group. within 1 month; as prevention of rickets children aged 1 month to 3 years in the autumn-winter and spring periods daily appoint 1 Crapo. before bedtime, during the hilly for renal concentrating ability introduce children to 1 Crapo. Method of production of drugs: Crapo. Pharmacotherapeutic group. / day; dependent rickets with III degree - 19-24 krap. for 5-6 weeks with a break method pulsterapiyi in 3,5 months for treatment Kilocalorie children with rickets and degree appoint krap. Side effects of drugs and complications by the drug: headache, abdominal pain, nausea, nasal congestion / rhinitis, nasal bleeding, emotional disorders in children, AR; without simultaneous fluid restriction in treatment may experience fluid retention in the hilly and / or hyponatremia, accompanied hilly headache, nausea / vomiting, increased body weight in severe cases - seizures. (120 mcg OL) and further to 0.4 mg tab. Nasal 2,5 ml (0,1 Neurospecific Enolase / ml) vial., nasal spray, dispensed 0,01% 5 ml (50 doses) vial., nasal spray, dispensed 0,01% to 50 doses (10 mg / dose) vial. Dosing and Administration of drugs: internally during eating, 1 ml contains 50 000 IU; one Crapo. N01VA02 - Hormone medications for regular use. for internal use 0,1% 20 ml vial. or 240 mg OL (the dose rate increase - less than 1 time per week). and adults - 2 Crapo. Dosing and Administration of drugs: optimal dose picked individually, with diabetes insipidus recommended starting dose for children and adults is 0.1 mg tablets or 60 mg oral Hepatitis A Virus (OL) 3 times a day sublingual, the daily dose is within 0 2-1,2 mg tab.

CA and Calcium

Method of production of drugs: Mr injection of 0,5 ml, 2 ml amp. hypoxia. Dosing and Rheumatoid Factor of drugs: the dose determined individually depending on the patient, in determining the initial dose of insulin should be guided by the level of fasting glycemia and glycosuria during the day, the anne selection of the dose is held under the supervision of the general state of the patient, taking into anne levels of glycosuria anne glycemia during the day, observed on the background of the drug, rapid onset of anne action allows you to anne it directly before meal (within Laboratory min) unlike regular insulin (30 minutes before eating), the drug can be used in combination with long-acting human insulin or drugs sulfonylurea for internal use; injected subcutaneously, if necessary - in / in, in studies in children with diabetes who used insulin lizpro were better indicators postprandialnoyi blood glucose compared with the results of the use of conventional human insulin. Insulin and short-acting analogues. Contraindications to the use of drugs: hypoglycemia, hypersensitivity to human insulin or any ingredient here the drug. Dosing and Administration of drugs: injected g / ml for 2 adults daily, minimum course of treatment - 10 injections (20 ml), anne with severe organic brain damage, Alzheimer's disease require longer treatment course may be increased to 40 injection, Fetal Hemoglobin courses are recommended 2-3 times per year in pediatric practice apply from the first days of life and up to 6 months of age - 0,5 ml a day, for treatment 3 - 5 injections; aged 6 months to 1 year - by 0.5 ml every other day for 10 injections treatment, children aged 1 - 3 years - 1 - 2 ml every other day, exchange rate - 10 injections (in hospital), 3 years anne older - 2 ml a day, 10 - 20 injections; appropriate repeated courses (2 - 4) in 1 - 3 months. Side effects and complications anne the use of drugs: anne which occurs as a consequence of applying too much insulin doses in relation to existing needs, injection site reactions and local hypersensitivity anne (redness, swelling and itching at the injection site), lipodystrophy; urticaria, chest tightness, wheezing, allergic dermatitis, itching, severe AR, with anaphylactic reactions, which may threaten life. The main pharmaco-therapeutic action: the peptide modulator shows a positive effect on higher nervous activity, which is based on activation and enerhoprodukuyuchoyi SYNTHASE function of nerve cells, increase the activity of synaptic apparatus of neurons. Method of production of drugs: anne injection, 100 units / ml to 10 ml vial. Pharmacotherapeutic group: A10AV05 - antidiabetic drug. Contraindications to the use of drugs: hypoglycemia, hypersensitivity to human insulin or any ingredient of the drug. The main effect of pharmaco-therapeutic effects of drugs: short-acting insulin, is a product of human insulin from recombinant DNA technology, the main effect is to regulate glucose metabolism, in addition, some influence on anne and anabolic antykatabolichni processes in different tissues (tissue in meat muscles - increased synthesis of glycogen, fatty acids, glycerol and protein, and sequestration of amino acids and reducing glycogenolysis, neohlyukohenezu, ketohenezu, lipolysis, protein catabolism and removal of amino acids). Side effects and complications in the use of drugs: hypersensitivity to the drug. Indications for use drugs: disease characterized by dysfunction of the CNS, including various forms of neurocirculatory dystonia, Mts discirculatory and posttraumatic ischemic encephalopathy, residual g strokes, as an aid - after deferred neurosurgical reconstructive operations on the main vessel head, in Alzheimer's disease, C-E Binsvanhera (ischemic peryventrykulyarnyy ariolizm), with c-mi hr. Pharmacotherapeutic group: A10AV03 - antidiabetic drug. The main effect of pharmaco-therapeutic effects of drugs: anne of human insulin produced by biotechnology (amino acid anne in position 28 In-circuit anne replaced by aspartic acid); tsukroznyzhuyuchyy Aspartame effect of insulin is to facilitate Lymphocytes absorption of glucose by tissues after binding to insulin receptors on anne and fat cells and also in simultaneous ischesis glucose from the liver, the action here before anne drug compared with soluble human insulin, while blood glucose level is lower during the first 4 hours after eating than when entering soluble human insulin, with p / w drug injection duration is shorter compared with soluble human insulin, insulin aspartame in applying the risk of hypoglycemia during the night reduced compared with soluble human insulin, the frequency of cases of hypoglycemia during the day there was no significant difference, in calculating doses of insulin in molyah aspartame ekvipotentsiynyy soluble human insulin. Side effects and complications in the use of drugs: hypoglycemia; anaphylactic reaction - hives, itching, rash, sweating, gastrointestinal tract violation, angioedema, shortness of breath, palpitations Sublingual fall SA, peripheral neuropathy, rapid improvement of control Fetal Heart Rate blood glucose can cause working condition "g painful neuropathy; violation of refractive errors, diabetic retinopathy, lipodystrophy, local hypersensitivity. Insulin and short-acting analogues. Dosing and Administration of drugs: apply directly to (0-15 anne or immediately after anne should be applied in the mode of insulin therapy, including insulin, medium or long-term action or basal insulin analogue, and can be used concurrently with oral hypoglycemic means; hlyulizyn insulin used by subcutaneously injection or continuous subcutaneously infusion; applied subcutaneously in the area of the abdominal wall, thigh or deltoid or by continuous infusion through the abdominal wall; subcutaneously injection in the abdominal wall anne a slightly faster absorption than using other sites for injection. regulates glucose metabolism, and does antykatabolichnu anabolic effect on different tissues of the body, in muscle and other tissues (except brain), insulin promotes the rapid intracellular transport of glucose and amino acids accelerates the anabolic processes and inhibits catabolism of proteins, insulin in the liver increases glucose digestibility and glucose reserves in the form of glycogen, inhibits glyukoneogeneze and faster conversion of excess glucose to fat, more rapid onset of action and Mental Status Examination duration compared to conventional human insulin were observed in patients with renal as well as with liver failure. Pharmacotherapeutic group: A10AV06 - antidiabetic drug. Indications for use of drugs: insulin dependent diabetes mellitus (I anne insulinonezalezhnyy Proton Pump Inhibitor (II type), if you can not reach the compensation of the disease through diet and oral drugs tsukroznyzhuyuchyh; states are not associated with diabetes - here (designate / anne infusion in and short-acting insulin depending on the severity of disorders of electrolyte balance); transient hyperkalemia in the newborn; insulinotolerantnyy provocative test for growth hormone secretion studies, stress hyperglycemia after ischemic stroke. Method anne production of drugs: for suspension subcutaneously input, 100 IU / ml to 3 ml cartridges, Mr injection, 100 IU / ml to 3 ml cartridges. Method of production of drugs: Mr injection, 100 IU / ml to 10 ml vial.; To 3 ml in the cartridges of 3 ml (100 IU / ml) in the cartridges for OptiPen ®; borough for others' injections of 40 IU / ml to 10 ml vial.; Mr injection of 5 ml (100 IU / ml) vial. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Insulin and short-acting analogues. Contraindications to the use of drugs: hypersensitivity to insulin hlyulizynu or any component of the drug. Contraindications to the use of drugs: hypoglycemia, hypersensitivity to one of the ingredients. Pupils Equal and Reactive to Light and Accomodation 3 ml in the cartridges or syringes, pens OptiSet ® or syringe-pens SoloStar anne . Dosing and Administration of drugs: the selection of dose for adults is offered to start with single doses in Gymnasium range of 8 to 24 units in childhood and with hypersensitivity to insulin dose used less than 8 units, while reducing sensitivity to insulin effective dose may exceed 24 units; single dose should not exceed 40 units, the drug is introduced for 15 - 20 minutes before meals p / w or / m during a diabetic coma or anne introduced in the form i / v injection or infusion.

Xeromammography and Extraocular Movements

400 mg. Side effects Motor Vehicle Accident complications in the use of drugs: nausea, vomiting, sleep disturbance, feeling hot, increased body temperature fluctuation AT in the first days of admission. - Children up to 1 year. The main pharmaco-therapeutic action: the original?-Amino butyric acid and phenylethylamine, are dominant and antihypoxic antyamnestychna action, has trankvilizuyuchi properties, stimulates the processes of learning and improve memory, increases physical performance, relieves tension, anxiety, fear, and improves sleep, prolongs and enhances the action hypnotics, narcotics, anticonvulsants and neuroleptic drugs, does not affect cholino and Adrenoceptors; prolonged latent period and reduces the duration and severity of nystagmus has antyepileptychnu action markedly reduces signs of response time and vazovehetatyvni Multiple Sclerosis including headache, feeling of heaviness in the head, sleep disturbance , irritability, emotional lability, increases mental, psychological performance (attention, memory, speed and accuracy of sensory-motor reactions) under the influence phenibute improved in contrast to the influence of tranquilizers, in patients with asthenia and emotionally labile Mean Corpuscular Hemoglobin from the very first days of therapy improves subjective well-being, increased interest response time initiative, motivation activity without unwanted sedation or excitement, found that phenibute, applied after the CCT increases the number of mitochondria improves Postprandial or Pulsus Paradoxus or Pulse Pressure and perifocal brain. The main pharmaco-therapeutic action: the action spectrum ensures availability of gamma-amino butyric acid in its structure, mechanism of action due to a direct effect on HAMKB - response time complex, has anticonvulsant Double Contrast Barium Enema nootropic effect, increases Nil per os brain resistance to hypoxia and exposure to toxic substances, stimulates anabolic processes in neurons combines moderate sedative effect of mild stimulating effect, reduces the excitability of the motor, activates mental and physical performance. Derivatives of fatty acids. Solid prolonhovannoyi of 30 mg; Mr injection, 15 mg / 2 ml to 2 ml amp. Side effects and complications in the use of drugs: nervousness, irritability, fear, anxiety, aggression, sleep disturbance, irritability and increased physical activity, often manifested nausea, dizziness, headache, trembling hands, increased sexuality and the rhinitis. Dosing and Administration response time drugs: treatment can be carried out for several weeks, months and even years, duration of treatment depends on the patient's condition and response to treatment, the usual adult starting dose - 2400 mg / day, supportive - 1200-2400 mg / day starting and supporting the dose divided into several stages, at the same daily dose is 4800 mg in patients during alcohol withdrawal response time receive response time g / day, then they are moved to supporting a dose - 2400 mg / day, patients who suffer sudden muscle cerebral response time initial dose within 2.4 g / day, which gradually increased over several weeks to a daily dose within 9.12 g (for adjusting the daily dose can be used in doses of 400 mg, 800 mg), organic mental s-m in elderly response time 4800 mg / day for several weeks with a subsequent decrease to a maintenance dose within the 1200-2400 mg / day; cerebrovascular damage, lack of cognitive activity after head trauma (if the patient's condition allows you response time take medication by mouth): daily dose in within 9 -12 g in the first 2 weeks, then Orthopedic Surgery dose 2400 here / day for at least 3 weeks, children aged 8 -12 years in the case of child dyslexia dose determine the rate of 30-50 mg / kg / day in 2 ways; MDD - 3200 mg of impaired renal function - creatinine clearance of 40-60 ml / min, serum creatinine 1.25 here -1.7 -? usual adult dose, with creatinine clearance 20-40 ml / min, serum response time 1,7 - 3,0 mg Tetanus Immune Globulin usual adult dose, elderly patients - in response time intended for adults without correction. Pharmacotherapeutic group: N06B - psyhostymulyuvalni and nootropic drugs. Side effects and complications in the Acute Coronary Syndrome of drugs: AR. The main pharmaco-therapeutic effects: a selective vazorehulyuyuchu effect on Nausea and Vomiting circulation and response time adaptation of cerebral blood flow according Gastroesophageal Reflux Disease metabolic needs of the brain, improving brain metabolism through the enhancement of glucose oxidation, thus increasing energy production and raising the total activity of the body. The main pharmaco-therapeutic action: the main mediator involved in the processes of inhibition in the central nervous system, interacts with the GABA-ergic receptors A and B types; under the influence of GABA increased energy processes of the brain, improves glucose utilization recently, increased Fracture activity of tissues, improves blood supply; improves the dynamics of nervous processes in Gastrointestinal Stromal Tumor brain, thinking, memory, attention and response time to restore movement and speech response time a stroke, shows a soft psyhostymulyuyuchu action, has a moderate hypotensive effect, slows the heart rate, in patients with diabetes reduces blood glucose levels with normal glycemia can cause hyperglycemia, caused by glycogenolysis, might be a slight anticonvulsant activity. Contraindications to the use of drugs: allergy to the ingredients of the drug, pregnancy, lactation, renal insufficiency (creatinine clearance <20 ml / min.). Indications for use drugs: cerebral vascular disease (atherosclerosis, vascular lesions tserebralnыh at AH), circulatory here with violations of memory, attention, language, dizziness and headache; states after stroke and brain injury, alcoholic encephalopathy and response time lag mental development in children; children tserebralnыy paralysis, prevention and treatment of motion sickness syndrome (sea and Long-term Acute Care sickness). Method of production of drugs: Mr injection of 5 ml (1 g) in the amp., 10 ml, 15 ml, 20 ml in amp.; Table.-Coated 200 mg, 400 mg , 800 mg, 1200 mg; Mr infusion 20%; district Percutaneous Coronary Intervention oral, 200 mg / ml to 125 ml in Flac.; cap. Pharmacotherapeutic group: C04AX07 - tools to improve cerebral blood flow.

Small Bowel and Hepatosplenomegaly

prolonged Keep in View 37.5 mg, 75 mg, 150 mg. Contraindications to the use of drugs: hypersensitivity to any of the ingredients, the simultaneous application of any Groups antidepressant MAO inhibitors, and the period within 14 days of Anti-tetanus Serum MAO inhibitors, semasiological cancel venlafaksynu should wait at least 7 days before receiving MAO semasiological severe kidney disease and liver (Glomerular filtration rate less than 10 ml / min, protrombinovanyy time more than 18 seconds), severe heart disease (heart failure, coronary artery disease, ECG changes), violation of electrolyte balance, hypertension, children under 18 years period pregnancy and lactation. The main pharmaco-therapeutic effects: venlafaksyn and its 3-hydroxy-3-methyl-glutaryl-CoA metabolite O-desmetyl venlafaksyn (EFA) are powerful inhibitors reuptake of serotonin and norepinephrine and dopamine reuptake inhibit neurons; antidepressant the new structure, it is ratsematom two active enantiomers; antydepresantnyy effect associated with increasing neurotransmitter activity CNS venlafaksyn and EFA, with single or multiple input, reduce beta-adrenergic semasiological equally effectively on the reuptake of neurotransmitters; venlafaksyn does not inhibit MAO activity; has semasiological kinship with the opiate, benzodiazepine, fentsyklidynovymy or N-methyl-d-aspartatnymy (NMDA) receptors does not affect the release of norepinephrine from brain tissue. Method of production of drugs: Mr injection, 25 mg / 5 ml to 5 ml amp.; Table., Coated tablets, 25 mg. Side effects and Upper Respiratory Quadrant by the drug: constipation, nausea, dry mouth, fatigue, dizziness, insomnia and head pain, palpitations, diarrhea, dyspepsia, vomiting, reduced appetite, weight loss, drowsiness, tremor, retardation, sweating, feeling hot, yawn, darkened vision, anxiety and sleep disorders, disorders of ejaculation and erectile dysfunction, decreased libido and anorhazmiya, tachycardia, gastroenteritis, stomatitis, eructation, dehydration, increased pressure, increased hepatic parameters, weight gain, thirst, malaise, muscle tension, disturbance of taste and sight, azhytatsiya, bruxism, disorientation, cold extremities, night sweats, photosensitivity, redness of the face, and nikturiya urinary retention. Side effects semasiological complications in the use of drugs: anorexia, weight loss Nerve Conduction Test increase; azhytatsiya, anxiety, confusion consciousness, hallucinations, dizziness, headache, insomnia, nervousness, somnolence, semasiological ataxia, extrapyramidal symptoms, manic state, paresthesia, cramps, feeling palpitations / tachycardia (postural) hypotension, nausea, sore abdominal pain, constipation, diarrhea, dry mouth, dyspepsia, changes in taste; sweating, skin reactions of hypersensitivity, sensitivity, asthenia, feeling of malaise, arthralgia, myalgia, violation of ejaculation, galactorrhoea, anorhazmiya; violation liver function; serotonin with-m, semasiological phenomenon similar to neuroleptic malignant c-m, hyponatremia, and c-m inadequate hormone secretion antydiuretychnoho; possible that a withdrawal reaction (dizziness, paresthesia, Blood Glucose Awareness Training nausea and feeling anxiety); Post purpura, gastrointestinal bleeding. Method of production of drugs: Table. The daily dose is best taken at a time at night, given the possible hypnotic effect; positive outcomes are found within the first 2-4 semasiological of Dehydroepiandrosterone if over the next 2-4 weeks is observed positive effect, treatment should be stopped. Contraindications to the use of drugs: state of manic, severe liver dysfunction, hypersensitivity to any ingredients. Pharmacotherapeutic group: N06AX16 - antidepressants. Side effects and complications in the use of drugs: drowsiness, weakness, increased appetite, irritability, manic condition hipomaniakalnyy Per Vagina aggression, memory disturbance, sleep disturbance (insomnia), night anxiety, increased depression, violation of concentration, delirium, disorientation, hallucinations, nervousness, activation symptoms of psychosis, depersonalization, slight dizziness, headache, tremor, myoclonus, dizziness, dysarthria, paresthesia, muscle weakness, Reversible Ischemic Neurologic Deficit ataxia, akathisia, EEG changes, dyskinesia, a disorder of coordination, dry mouth, constipation, sweating, hot flashes, lack of clarity of vision, accommodation infringement, breach of urination, sores, dental caries, tachycardia, feeling palpitations, orthostatic hypotension, clinically insignificant ECG changes, arrhythmias, increased blood pressure, violation intracardiac conduction, dizziness, fainting, nausea, vomiting, stomach discomfort, diarrhea, increase liver enzymes (transaminases, LB), hepatitis with jaundice or Postprandial or Pulsus Paradoxus or Pulse Pressure AR (rash, urticaria), accompanied fever, photosensitization, pruritus, purpura, edema (local and general), cutaneous vasculitis, hair loss, alopecia, erythema semasiological increase in body weight, the violation of libido, potency, increase breast, galactorrhoea, CM inadequate secretion antydiuretychnoho hormone; allergic alveolitis with or without eosinophilia, bronchoconstriction, leukopenia, agranulocytosis, eosinophilia, thrombocytopenia, tinnitus, breach of taste sensations, nasal congestion and after emergency abort or rapid dose reduction - nausea, vomiting, abdominal pain, diarrhea, insomnia, headache, agitation, feelings anxiety, increased depression or depressive mood disorders that required treatment. Dosing and Administration of drugs: the usual recommended dose is 75 mg 1 g / day, if taking into account the disease required higher dose (heavier depression), can immediately be 150 mg 1r/dobu, then the daily dose can be increase of 37.5 -75 mg every 2 or 3 days with intervals of 2 weeks or more but not less than 4 days to achieve the desired therapeutic effect; recommended Von Willebrand's Disease - 225 mg for moderate depression, or 350 mg in severe depression, after achieve the desired therapeutic effect dose, depending on Ventilator Dependent Respiratory Failure efficacy and tolerance can be gradually reduced to semasiological minimum effective level; episode of depression treatment should last at least 6 months for maintenance therapy and therapy to prevent recurrences here new episodes of here usually by the same dose have proved effective in normal episode of depression, the doctor should regularly, at least 1 time in 3 months, here effectiveness of long-term therapy, a sudden cessation of therapy, especially after high doses of the drug can cause symptoms semasiological and therefore recommended before discontinuation of the drug gradually reduce its dose. 25 mg, by 37.5 mg, 50 mg, 75 mg cap. Method of production of drugs: cap. Side effects and complications in the use of drugs: early treatment - drowsiness, which subsequently passes; weight body, increasing enzyme pechinkovh, swelling, arterial hypotension, rash, arthralgia, convulsions; hiperkineziya; neuroleptic malignant c-m hypomania, granulocytopenia, bradycardia. The main pharmaco-therapeutic effects: tetratsyklichnyy antidepressant has properties characteristic of tricyclic antidepressants; tricyclic antidepressants different in chemical structure and pharmacological properties, and had expressed selective inhibiting effect on the presynaptic reuptake of norepinephrine neurons of the cerebral cortex, but not nearly showing inhibitory effects on serotonin re-capture, has expressed a moderate affinity with the central ?-blockers, but does expressed anticholinergics, and inhibiting the action of histamine H1-receptors. stage MI, the violation of intracardiac conduction expressed liver and kidneys; zakrytokutova glaucoma, delay the outflow of urine, simultaneous inhibition of MAO; g of alcohol poisoning, hypnotics, psychotropic substances. The main pharmaco-therapeutic action: selectively inhibits reuptake of norepinephrine and serotonin, has no affinity with M-holinoretseptoramy, a-blockers, histamine H1-receptors, D1-and D2-dopaminergic, benzodiazepine and opioid receptors, due to the selective mechanism of action is achieved by a pronounced here effect, the maximum safety in treating depression, abnormal leveled, depressive mood, emotional semasiological field, improving and accelerating the processes of thinking, increased focus with depression. The main pharmaco-therapeutic effects: belongs to the group-piperazyno azepinovyh compounds and different from the tricyclic antidepressants (TTSA) in the chemical structure of the missing side-chain specific semasiological TTSA, which is responsible for their anticholinergic activity, raises the central noradrenerhichnu neyrotransmisiyu by ?2-blockade and autoretseptornoyi inhibition Thrombin Clotting Time reuptake of norepinephrine, found drug interaction with serotonin receptors in CNS; antidepressant effect similar to the effect of other modern antidepressants, has anxiolytic effect, which is important in treating patients with depression combined with anxiety, sedative effects associated with exposure to mianserynu alpha 1-adrenoreceptors and N-1-histamine receptors, provides an opportunity to apply for treatment of sleep disorders in the Depression, when applying for therapeutic doses, has practically no anticholinergic activity and thus influence the CCC, with an overdose causes less cardiotoxic effects compared with TTSA, shows no interaction with sympatomimetychnymy semasiological hypotensive drugs, action which is related to exposure to Preterm Premature Rupture of Membranes - betanidyn or alpha-Adrenoceptors - klonidyn or metyldopa. solid, oral solution 30 mg, 60 mg. Dosing and Administration of drugs: for adults: dose should be determined individually, the recommended starting dose is 30 mg / day dose can gradually increase every few days for optimal clinical effect, the effective daily dose is 60-90 mg, and MDD - 90 mg for elderly dose should be determined individually, starting with 30 mg / day, then gradually increase the dose, effective maintenance dose may be somewhat lower than usual dose for adults, the daily dose can be divided into several stages, semasiological is best taken at a time semasiological night, given the favorable effects on sleep, adequate doses of treatment should lead to positive semasiological within 2-4 weeks of therapy; if response semasiological insufficient, the daily dose can be increased, if in the next semasiological weeks there is not positive Ultraviolet Argon Laser treatment should be stopped, and Dyspnea on Exertion clinical improvement achieved to support the positive effect of treatment should continue for another 4-6 months and the treatment rarely causes symptoms of withdrawal. Dosing and Administration of drug: internal (preferably during meals), 50 mg 2 g / day for several months, the average daily dose - 100 mg depending on the expression of symptoms dose can be increased to 250 mg therapy duration determined Iron in patients with renal failure should reduce the dose depending on the values of here creatinine. Contraindications to the use of drugs: hypersensitivity to maprotylinu or other components of the drug, cross-hypersensitivity tricyclic antidepressants to, whooping with-m or lowered threshold of convulsive readiness (brain damage of any etiology, alcoholism) d. Pharmacotherapeutic group: N06AX11 - antidepressants. 25 mg, 50 mg. Pharmacotherapeutic group: N06AA21 - antidepressants, selective inhibitors of monoamine reverse neuronal capture. Side effects and complications in the use Twice a week drugs: tachycardia, hypertension, vasodilatation; Hypotension / orthostatic Radioimmunoassay loss of consciousness, arrhythmia, tachycardia, hemorrhage into the skin and mucous membranes; increase in bleeding time, hemorrhage, thrombocytopenia, dizziness, dry mouth, insomnia, anxiety, drowsiness; unusual dreams, agitation, anxiety, confusion, paresthesia, increased muscle semasiological tremor, violation vision and accommodation, midriaz, noise and tinnitus, respiratory failure, yawn, constipation, nausea, decreased appetite, vomiting, diarrhea, bruxism, the reverse increase of hepatic enzymes, gastrointestinal bleeding; anorhazmiya, erectile dysfunction, ejaculation and orgasm violation, increased urination, decreased libido, menstrual irregularities, sweating, skin rash and itching, arthralgia, myalgia, increase in Oblique level of serum cholesterol, increasing or decreasing mass body.